Shenzhen Shenxin Biotechnology Co., Ltd
5 clinical trials · Sponsor
◉ Watch Shenzhen Shenxin Biotechnology Co., Ltd
| Record | Firm | Date |
|---|---|---|
| A Phase 2 Study to Describe the Safety, Reactogenicity, and Immunogenicity of Herpes Zoster IN001 mRNA Vaccine (IN001) in Healthy Participants (NCT07205796) | Shenzhen Shenxin Biotechnology Co., Ltd | 2026-05-01 |
| A Phase 2 Study to Describe the Safety and Immunogenicity of Respiratory Syncytial Virus Vaccine IN006 in Healthy Participants Aged 60 Years and Older (NCT07128121) | Shenzhen Shenxin Biotechnology Co., Ltd | 2025-08-13 |
| A Study to Describe the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine IN006 in Healthy Adult Aged 18 Years and Above (NCT06645665) | Shenzhen Shenxin Biotechnology Co., Ltd | 2024-11-11 |
| A Study to Describe the Safety, Reactogenicity, and Immunogenicity of Herpes Zoster IN001 mRNA Vaccine (IN001) in Healthy Participants (NCT06375512) | Shenzhen Shenxin Biotechnology Co., Ltd | 2024-07-05 |
Track Shenzhen Shenxin Biotechnology Co., Ltd automatically
Every clearance here is in the API, with alerts when new ones post.